SCHEMBL6413243

SCHEMBL6413243

FN(C(F)(F)F)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3945384 0.84
SCHEMBL30947367 0.84
SCHEMBL6408306 0.79
SCHEMBL17092892 0.74 LMNA (0.36)
SCHEMBL7050738 0.74 LMNA (0.36)
SCHEMBL7050459 0.74 LMNA (0.36)
SCHEMBL621185 0.74
SCHEMBL9636964 0.69 LMNA (0.32)
SCHEMBL7949744 0.67 LMNA (0.36)
SCHEMBL17092890 0.67 LMNA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3384508-B1 METHODS FOR DIELECTRICALLY INSULATING ELECTRICAL ACTIVE PARTS SOLVAY (BE) 2020-02-26 EP disclosed
US-20180350483-A1 METHODS FOR DIELECTRICALLY INSULATING ELECTRICAL ACTIVE PARTS SOLVAY SA (BE) 2018-12-06 US disclosed
EP-3384508-A1 METHODS FOR DIELECTRICALLY INSULATING ELECTRICAL ACTIVE PARTS Solvay SA (BE) 2018-10-10 EP disclosed
WO-2017093501-A1 METHODS FOR DIELECTRICALLY INSULATING ELECTRICAL ACTIVE PARTS SOLVAY SA (BE) 2017-06-08 WO disclosed
US-20050053552-A1 Phase shift colloids as ultrasound contrast agents QUAY STEVEN C (US) 2005-03-10 US disclosed
US-6569404-B1 Aqueous colloidal suspension, dispersed phase is gas microbubbles of perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane or sulfur hexafluoride; fluorinated amphiphile for stabilizing microbubbles AMERSHAM HEALTH A/S (NO) 2003-05-27 US disclosed
US-6245319-B1 Colloidal dispersions of perfluoropentane SONUS PHARMACEUTICALS, INC. 2001-06-12 US disclosed
EP-0680341-B1 PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS SONUS PHARMA INC (US) 2001-05-09 EP disclosed
EP-1038535-A2 Use of selected perfluorocarbons for the preparation of diagnostic ultrasound contrast agents SONUS PHARMACEUTICALS, INC. (US) 2000-09-27 EP disclosed
EP-0680341-A1 PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS SONUS PHARMACEUTICALS, INC. (US) 1995-11-08 EP disclosed
WO-1994016739-A1 PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS SONUS PHARMACEUTICALS, INC. (US) 1994-08-04 WO disclosed